These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18473376)

  • 1. Baseline scintigraphic abnormalities by myocardial perfusion imaging predict echocardiographic response to cardiac resynchronization therapy in nonischemic cardiomyopathy.
    Adelstein EC; Saba S
    Clin Cardiol; 2008 May; 31(5):217-24. PubMed ID: 18473376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy.
    Adelstein EC; Saba S
    Am Heart J; 2007 Jan; 153(1):105-12. PubMed ID: 17174647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy.
    Adelstein EC; Tanaka H; Soman P; Miske G; Haberman SC; Saba SF; Gorcsan J
    Eur Heart J; 2011 Jan; 32(1):93-103. PubMed ID: 20971745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy restored ventricular septal myocardial perfusion and enhanced ventricular remodeling in patients with nonischemic cardiomyopathy presenting with left bundle branch block.
    Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Shimizu W
    Heart Rhythm; 2014 May; 11(5):836-41. PubMed ID: 24561161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of intraventricular dyssynchrony assessment by gated-SPECT myocardial perfusion imaging in the management of heart failure patients undergoing cardiac resynchronization therapy (VISION-CRT).
    Peix A; Karthikeyan G; Massardo T; Kalaivani M; Patel C; Pabon LM; Jiménez-Heffernan A; Alexanderson E; Butt S; Kumar A; Marin V; Mesquita CT; Morozova O; Paez D; Garcia EV
    J Nucl Cardiol; 2021 Feb; 28(1):55-64. PubMed ID: 30684258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter imaging.
    Bertini M; Delgado V; den Uijl DW; Nucifora G; Ng AC; van Bommel RJ; Borleffs CJ; Boriani G; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):86-93. PubMed ID: 19920028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.
    Wang NC; Hussain A; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Shalaby AA; Voigt AH; Saba S
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12603. PubMed ID: 30267454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy.
    Middour TG; Rosenthal TM; Abi-Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Bober RM; Morin DP
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1137-1146. PubMed ID: 32064730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.
    Sood N; Al Badarin F; Parker M; Pullatt R; Jacobson AF; Bateman TM; Heller GV
    J Nucl Cardiol; 2013 Oct; 20(5):813-20. PubMed ID: 23864400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume overload modulates effects of cardiac resynchronization therapy independently of myocardial reperfusion: results of the RESYNC study.
    Gimelli A; Stanislao M; Valle G; Frumento P; Zanco P; Ometto R; Inglese E; Martino G; Startari U; Bertelli P; Marzullo P
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):575-81. PubMed ID: 17667027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Myocardial Contrast-Enhanced T
    Höke U; Khidir MJ; van der Geest RJ; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 May; 119(9):1456-1462. PubMed ID: 28274575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study.
    Wang NC; Li JZ; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):143-154. PubMed ID: 29314085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to the selection of an appropriate pacing position for optimal cardiac resynchronization therapy using CT coronary venography and myocardial perfusion imaging: FIVE STaR method (fusion image using CT coronary venography and perfusion SPECT applied for cardiac resynchronization therapy).
    Tada T; Osuda K; Nakata T; Muranaka I; Himeno M; Muratsubaki S; Murase H; Sato K; Hirose M; Fukuma T
    J Nucl Cardiol; 2021 Aug; 28(4):1438-1445. PubMed ID: 31435883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT?
    Henneman MM; Chen J; Dibbets-Schneider P; Stokkel MP; Bleeker GB; Ypenburg C; van der Wall EE; Schalij MJ; Garcia EV; Bax JJ
    J Nucl Med; 2007 Jul; 48(7):1104-11. PubMed ID: 17574987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy.
    Sciagrà R; Giaccardi M; Porciani MC; Colella A; Michelucci A; Pieragnoli P; Gensini G; Pupi A; Padeletti L
    J Nucl Med; 2004 Feb; 45(2):164-8. PubMed ID: 14960631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
    Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective prediction of response to cardiac resynchronization therapy using a novel program of gated myocardial perfusion single photon emission computed tomography.
    Nakamura K; Takami M; Shimabukuro M; Maesato A; Chinen I; Ishigaki S; Higa S; Keida T; Masuzaki H
    Europace; 2011 Dec; 13(12):1731-7. PubMed ID: 21873328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.